跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 3,878 条关于
“SZR-047”
全部
3,878
临床试验
2,181
药物
1,501
机构
17
资讯
179
去年
Surrozen's SZR-047 Meets Primary Endpoint in Phase III Trial for Muscle Disease
12个月前
FDA Clears First-in-Human Trial for LBL-047, Novel Bispecific Protein Targeting Autoimmune Diseases
9个月前
Leads Biolabs and Dianthus Therapeutics Initiate Phase 1 Trial of Novel Bifunctional Autoimmune Therapy LBL-047
上个月
BMS Launches India's First LAG-3-Based Dual Immunotherapy for Metastatic Melanoma
去年
BRAF Status and Response Kinetics Guide First-line Immunotherapy Selection in Advanced Melanoma
去年
Nivolumab/Relatlimab Combination Demonstrates Sustained Overall Survival Benefit in Advanced Melanoma
去年
BMS's Opdualag Shows Strong Early Performance as First LAG-3 Checkpoint Inhibitor for Melanoma
去年
Next-Generation Cancer Therapies: Advances in Checkpoint Inhibitors and Personalized Treatment
去年
Secukinumab Shows Superior Efficacy Over Ustekinumab in Clearing Skin for Generalized Pustular Psoriasis
去年
Ovarian Cancer Survival Disparities Revealed Among Asian American Subgroups Despite Overall Lower Mortality Rates
第 1 页,共 18 页
上一页
下一页